 |
|
Diagnosis and Treatment of Latent Tuberculosis Infection due to Initiation of Anti-TNF Therapy
Tae Sun Shim
Tuberc Respir Dis. 2014;76(6):261-268. Published online 2014 Jun 28 DOI: https://doi.org/10.4046/trd.2014.76.6.261
|
|
Citations to this article as recorded by
 Implementation of risk minimization measures to reduce the risk of tuberculosis among tumor necrosis factor medication users
Nouf Al‐Fadel, Abdulaali Almutairi, Tahrir Aldhirgham, Laila Abuesba, Adel Alrwisan, Fawaz Alharbi
Pharmacoepidemiology and Drug Safety.2024;[Epub] CrossRef Combined analysis of host IFN-γ, IL-2 and IP-10 as potential LTBI biomarkers in ESAT-6/CFP-10 stimulated blood
Antony M. Rapulana, Thabo Mpotje, Omolara O. Baiyegunhi, Hlumani Ndlovu, Theresa K. Smit, Timothy D. McHugh, Mohlopheni J. Marakalala
Frontiers in Molecular Medicine.2024;[Epub] CrossRef Treatments of Mycobacterium tuberculosis and Toxoplasma gondii with Selenium Nanoparticles
Ikhazuagbe H. Ifijen, Best Atoe, Raphael O. Ekun, Augustine Ighodaro, Ifeanyi J. Odiachi
BioNanoScience.2023; 13(1): 249. CrossRef Management and monitoring of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management,
Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen Calixto Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw
Journal of Gastroenterology and Hepatology.2023; 38(4): 510. CrossRef The Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea
Myeong Geun Choi, Byong Duk Ye, Suk-Kyun Yang, Tae Sun Shim, Kyung-Wook Jo, Sang Hyoung Park
Journal of Korean Medical Science.2022;[Epub] CrossRef Risk of tuberculosis infection and serial changes in interferon‐gamma release assays in elderly patients with psoriasis receiving biologic therapy
Taehan Koo, Gayun Baek, Mihn‐Sook Jue
The Journal of Dermatology.2022; 49(9): 887. CrossRef Hepatitis B Virus Reactivation and Mycobacterial Infections Associated With Ustekinumab: A Retrospective Study of an International Pharmacovigilance Database
Jingjing Wang, Xiaozhen Geng, Xin Zhang, Yanfeng Xiao, Wenjun Wang
Frontiers in Pharmacology.2022;[Epub] CrossRef Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study
Yeo-Jin Song, Soo-Kyung Cho, Hyoungyoung Kim, Hye Won Kim, Eunwoo Nam, Sang-Cheol Bae, Dae Hyun Yoo, Yoon-Kyoung Sung
Journal of Korean Medical Science.2021;[Epub] CrossRef Immune Subtyping in Latent Tuberculosis
Ushashi Banerjee, Priyanka Baloni, Amit Singh, Nagasuma Chandra
Frontiers in Immunology.2021;[Epub] CrossRef Frequency of Positive Conversion of Interferon-Gamma Release Assay Results Among Patients With Inflammatory Bowel Disease Treated With Non-tumor Necrosis Factor Inhibitors
Kyuwon Kim, Kyung-Wook Jo, Tae Sun Shim, Jin Hwa Park, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
Frontiers in Medicine.2021;[Epub] CrossRef Diagnosis and treatment of latent tuberculosis infection in patients undergoing treatment with immunobiologic agents: a four-year experience in an endemic area
Diana Maria de Almeida Lopes, Valéria Goes Ferreira Pinheiro, Helena Serra Azul Monteiro
Jornal Brasileiro de Pneumologia.2019;[Epub] CrossRef Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?
Filiz Akyuz, Bilger Cavus, Raim Iliaz, Ozlem M. Soyer, Asli Ormeci, Sami Evirgen, Semen Onder, Kaya Koksalan, Metin Keskin, Cetin Karaca, Kadir Demir, Mine Gulluoglu, Tulin Cagatay, Fatih Besisik, Sabahattin Kaymakoglu
European Journal of Gastroenterology & Hepatology.2019; 31(7): 777. CrossRef Miliary tuberculosis presenting as a choroidal mass and a tuberculosis screening review
Adam M. Kase, Claudia R. Libertin, Archana Roy
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.2018; 13: 13. CrossRef Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease
Jieun Kang, Dae Hyun Jeong, Minkyu Han, Suk-Kyun Yang, Jeong-Sik Byeon, Byong Duk Ye, Sang Hyoung Park, Sung Wook Hwang, Tae Sun Shim, Kyung-Wook Jo
Journal of Korean Medical Science.2018;[Epub] CrossRef Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA
Dae Hyun Jeong, Jieun Kang, Young Ju Jung, Bin Yoo, Chang-Keun Lee, Yong-Gil Kim, Seokchan Hong, Tae Sun Shim, Kyung-Wook Jo, Joan A. Caylà
PLOS ONE.2018; 13(7): e0198756. CrossRef Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?
John-Leonardo Torres-Castiblanco, Jorge Alberto Carrillo, Daniel Hincapié-Urrego, Adriana Rojas-Villarraga
Biomédica.2018; 38(1): 17. CrossRef Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization
Ravy K Vajravelu, Mark T Osterman, Faten N Aberra, Jason A Roy, Gary R Lichtenstein, Ronac Mamtani, David S Goldberg, James D Lewis, Frank I Scott
Inflammatory Bowel Diseases.2018; 24(1): 217. CrossRef Mycobacterium tuberculosis: An Adaptable Pathogen Associated With Multiple Human Diseases
Qiyao Chai, Yong Zhang, Cui Hua Liu
Frontiers in Cellular and Infection Microbiology.2018;[Epub] CrossRef Tuberculosis and biologics in rheumatology: A special situation
Rohini Handa, Sundeep Upadhyaya, Sanjiv Kapoor, Ramesh Jois, Bimlesh D. Pandey, Anuj K. Bhatnagar, Ashwani Khanna, Vishal Goyal, Kamal Kumar
International Journal of Rheumatic Diseases.2017; 20(10): 1313. CrossRef Association between TNF -308G/A polymorphism and susceptibility to pulmonary tuberculosis in the Lur population of Iran
Farhad Shahsavar, Ali Mohammad Varzi, Alireza Azargoon
Asian Pacific Journal of Tropical Biomedicine.2016; 6(1): 80. CrossRef How Should We Manage Latent Tuberculosis Infection in Patients Receiving Anti-TNF-α Drugs: Literature Review
Hamid Reza Naderi, Fereshte Sheybani, Susan Rezaei Pajand
Iranian Red Crescent Medical Journal.2016;[Epub] CrossRef Clinical Applications of Interferon-gamma Release Assays
Kwang-Sook Woo, Kyeong-Hee Kim
Laboratory Medicine Online.2016; 6(1): 8. CrossRef Cellular analyses in the monitoring of autoimmune diseases
Ulrich Sack, Andreas Boldt, Nora Mallouk, Rudolf Gruber, Veit Krenn, Anne-Emmanuelle Berger-Depincé, Karsten Conrad, Attila Tarnok, Claude Lambert, Dirk Reinhold, Stephan Fricke
Autoimmunity Reviews.2016; 15(9): 883. CrossRef Estimation of the prevalence of latent tuberculosis infection in patients with moderate to severe plaque psoriasis in Spain: The Latent study
M. Ribera, A. Zulaica, C. Pujol, M.L. Alonso, I.M. Rodriguez, C. Garcia-Calvo
Actas Dermo-Sifiliográficas (English Edition).2015; 106(10): 823. CrossRef The Risk of Tuberculosis in Korean Patients with Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-α Blockers
Ja Min Byun, Chang Kyun Lee, Sang Youl Rhee, Hyo-Jong Kim, Jung-Wook Kim, Jae-Jun Shim, Jae Young Jang
Journal of Korean Medical Science.2015; 30(2): 173. CrossRef Diagnosis and Treatment of Latent Tuberculosis Infection
Seung Heon Lee
Tuberculosis and Respiratory Diseases.2015; 78(2): 56. CrossRef QuantiFERON-TB Gold In-Tube Assay for Screening Arthritis Patients for Latent Tuberculosis Infection before Starting Anti-Tumor Necrosis Factor Treatment
Hyun Lee, Hye Yun Park, Kyeongman Jeon, Byeong-Ho Jeong, Ji-Won Hwang, Jaejoon Lee, Hoon-Suk Cha, Eun-Mi Koh, Eun-Suk Kang, Won-Jung Koh, Jean Louis Herrmann
PLOS ONE.2015; 10(3): e0119260. CrossRef Mycobacteria and autoimmunity
F Machado Ribeiro, T Goldenberg
Lupus.2015; 24(4-5): 374. CrossRef Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus
Katharina Ronacher, Simone A. Joosten, Reinout van Crevel, Hazel M. Dockrell, Gerhard Walzl, Tom H. M. Ottenhoff
Immunological Reviews.2015; 264(1): 121. CrossRef Estimación de la prevalencia de infección tuberculosa latente en pacientes con psoriasis en placas moderada a grave en España. Estudio Latent
M. Ribera, A. Zulaica, C. Pujol, M.L. Alonso, I.M. Rodriguez, C. Garcia-Calvo
Actas Dermo-Sifiliográficas.2015; 106(10): 823. CrossRef Detecting latent tuberculosis in compromised patients
Ilaria Sauzullo, Vincenzo Vullo, Claudio M. Mastroianni
Current Opinion in Infectious Diseases.2015; 28(3): 275. CrossRef New Advances in Diagnosis of Latent Tuberculosis Infection: A Review Article
Masoud Mardani, Zahra Abtahian
Archives of Pediatric Infectious Diseases.2014;[Epub] CrossRef
|